FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
FURX was delisted on the 1st of July, 2014.
2 hedge funds and large institutions have $1.61M invested in FURIEX PHARMACEUTICALS INC COM STK (DE) in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
13% more capital invested
Capital invested by funds: $1.42M → $1.61M (+$185K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
+$185K |
Top Sellers
FURX Hedge Fund Activity: Q3 2015 in Review
2 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) for Q3 2015, worth a combined $1.61M — up 13% from $1.42M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new FURX positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Metropolitan Life Insurance Company (MetLife), opening a new position worth an estimated $185K.
- 2 institutional investors held FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) as of Q3 2015, up from 1 in Q2 2015.
- Funds reported $1.61M of FURIEX PHARMACEUTICALS INC COM STK (DE) stock for Q3 2015, up 13% quarter-over-quarter.
- 1 fund opened new FURIEX PHARMACEUTICALS INC COM STK (DE) positions in Q3 2015 and 0 closed out, a net change of +1 holder.
- The largest FURIEX PHARMACEUTICALS INC COM STK (DE) buyer in Q3 2015 was Metropolitan Life Insurance Company (MetLife), an estimated $185K added.
Based on aggregated 13F filings for Q3 2015.